An implantable microchip has been developed which promises to deliver medicines regularly for complete one year. The study which has been published in the Journal Science Translational Medicine will take at least two years to reach in the market. However, the US will not be able to see the microchip until late in the decade.

Robert Farra, who is the President of MicroChips and lead author of the study, revealed that implantable microchip will finish the work of injections. It will be able to provide regular medicines effectively to osteoporosis, multiple sclerosis patients as well as other who have chronic pain in certain parts of the body.

The study involved 20 women, but Farra told that they need to conduct a large scale clinical trials. Only then they will be able to ask regulatory authorities to give green signal to its implantable microchip. The clinical trials and increasing the drug reservoir in the chip will take almost two years, said Farra.

In the study, 20 post-menopausal women were enrolled who also had osteoporosis. The implantable microchip was fitted in their abdomen for 20 days. It was found that the chip was more effective in providing drugs to the body and that too without any pain. Farra told that the microchip is programmed wirelessly, so there is no problem to deliver the medicine in the body.

The injections are quite painful for patients and especially for those who are already under great pain. This method will be quite effective in reducing the pain.

The co-author of the study Robert Neer, who is Director of the Massachusetts General Hospital Bone Density Center, said that they need to work on the basic structure of the chip so the chip remains a complete success. He further affirmed, "The major advantage of the chip is that the patient takes every dose that is prescribed”.